大动脉狭窄和壁剪压对血小板功能的影响
Paweł Bańka1, Maciej Wybraniec1, Tomasz Bochenek1
1First Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, 40-635 Katowice, Poland.
Journal of clinical medicine
|October 14, 2023
概括
大动脉狭窄 (AS) 导致高剪压,导致出血障碍和血小板激活. 本综述探讨了AS和AS的情况.
科学领域:
- 心血管医学 心血管医学
- 血液学 血液学 血液学
- 病理生理学 病理生理学
背景情况:
- 大动脉狭窄症 (AS) 是老年人普遍存在的疾病,其特征是渐进性的大动脉叶片变性,纤维化和化.
- 由此产生的动荡的血流和升高的剪切应力显著影响心血管健康和血液静止.
- 了解AS的发病过程对于开发有效的治疗策略至关重要.
研究的目的:
- 在AS的背景下,审查有关高剪压诱导的静血性疾病的当前知识.
- 探索AS对血小板功能和激活的影响.
- 讨论AS患者抗血小板治疗的影响.
主要方法:
- 关于AS,剪切应力和血液静止现有研究的文献综述.
- 分析了将动荡血流与·维勒布兰德因子降解和血小板激活联系在一起的机制.
- 综合有关血小板及其介质在AS病变发生中的作用的信息.
主要成果:
- 在AS中增加的剪切应力可以降低·威勒布兰德因子,可能导致粘膜出血.
- 高剪压还促进了血栓释放和血小板激活,即使在获得的·维勒布兰德综合征.
- 动荡的流动激活内皮和大动脉表面,促进血小板粘附和媒介释放,包括亲骨质因子.
结论:
- 由于AS引起的高剪压会引发复杂的静血性疾病,包括凝血,纤维素分解和血小板功能障碍.
- 血小板激活和媒介释放在AS的进展中发挥着重要作用.
- 对这些机制的进一步研究对于优化AS患者的抗血小板治疗至关重要.
更多相关视频
相关概念视频
01:22Mitral Stenosis I: Introduction
15
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15
01:22Formation of the Platelet Plug
6.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.5K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
538
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
538
01:27Mitral Stenosis IV: Nursing Management
13
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
13
01:26Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12